perimenopausal


Also found in: Dictionary, Thesaurus, Encyclopedia.

perimenopausal

adjective Referring to the time period around menopause at which the production of female sex hormones is reduced.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

perimenopausal

adjective Referring to a period of a ♀'s life–age 45 to 55-ish–in which menstrual periods become irregular; perimenopause is immediately before, during and after menopause. See Menopause.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Three (1.3%) women in the perimenopausal cohort and 16 (6.7%) women in the postmenopausal cohort had a serum hCG concentration that was greater than the conventional cutoff of 5.0 IU/L (12).
In the present study, we compared the menopausal symptoms among three different groups, namely, premenopausal, perimenopausal, and postmenopausal.
Out of these, 43 (60.5%) were premenopausal patients (<40 yrs.), 17 (23.9%) were perimenopausal and 11 (15.4%) were postmenopausal patients.
sites who were peror early perimenopausal at enrollment.
Framework provided for managing depressive disorders in perimenopausal women
A comparative study of serum lipid profile and premenopausal, perimenopausal and postmenopausal healthy women: Hospital based study in Jharkhand, India.
One of the oral lesions that is OLP is an outcome of such deficiencies reported among female population of pre and perimenopausal age bracket.
Other risk factors for perimenopausal depression included sociodemographic (black race, financial difficulties) and psychosocial factors (adverse life events, low social support), anxiety, and menopausal symptoms such as interrupted sleep and vasomotor symptoms.
Other risk factors for perimenopausal depression included socio-demographic (black race, financial difficulties) and psychosocial factors (adverse life events, low social support), anxiety, and menopausal symptoms such as interrupted sleep and vasomotor symptoms.
Perimenopausal women were found to be the leading cause for abnormal uterine bleeding constituting about 60.04%.
Using Pivot's drug formulation and delivery platform technologies, the company will develop and commercialise a topical cream containing cannabinoid product PVT-N005 for perimenopausal, menopausal and post-menopausal women who have noticed a decline in sexual desire and response.
Utilising its drug formulation and delivery platform technologies, the company will develop and aim to commercialise a topical cream containing cannabinoids (PVT-N005) for perimenopausal, menopausal and post-menopausal women who have noticed a decline in sexual desire and response.